nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP1B1—breast cancer	0.106	0.307	CbGaD
Omeprazole—ABCG2—breast cancer	0.0729	0.211	CbGaD
Omeprazole—CYP1A1—breast cancer	0.0571	0.166	CbGaD
Omeprazole—CYP2D6—breast cancer	0.0425	0.123	CbGaD
Omeprazole—CYP3A4—breast cancer	0.0364	0.106	CbGaD
Omeprazole—ABCB1—breast cancer	0.0303	0.088	CbGaD
Omeprazole—CYP1A1—Toremifene—breast cancer	0.0226	0.0559	CbGbCtD
Omeprazole—CYP1B1—Tamoxifen—breast cancer	0.0188	0.0465	CbGbCtD
Omeprazole—CYP1B1—Mitoxantrone—breast cancer	0.0184	0.0454	CbGbCtD
Omeprazole—ABCC3—Fluorouracil—breast cancer	0.0161	0.0397	CbGbCtD
Omeprazole—CYP1B1—Paclitaxel—breast cancer	0.0147	0.0362	CbGbCtD
Omeprazole—CYP1A2—Anastrozole—breast cancer	0.0111	0.0273	CbGbCtD
Omeprazole—CYP1B1—Docetaxel—breast cancer	0.0106	0.0262	CbGbCtD
Omeprazole—CYP1A2—Toremifene—breast cancer	0.0101	0.025	CbGbCtD
Omeprazole—CYP2C9—Anastrozole—breast cancer	0.00996	0.0246	CbGbCtD
Omeprazole—CYP2C8—Lapatinib—breast cancer	0.00953	0.0235	CbGbCtD
Omeprazole—ABCC3—Doxorubicin—breast cancer	0.00915	0.0226	CbGbCtD
Omeprazole—ABCG2—Tamoxifen—breast cancer	0.00896	0.0221	CbGbCtD
Omeprazole—ABCC3—Methotrexate—breast cancer	0.00886	0.0219	CbGbCtD
Omeprazole—ABCB1—Toremifene—breast cancer	0.00884	0.0218	CbGbCtD
Omeprazole—ABCG2—Mitoxantrone—breast cancer	0.00874	0.0216	CbGbCtD
Omeprazole—CYP1A1—Tamoxifen—breast cancer	0.00827	0.0204	CbGbCtD
Omeprazole—CYP2C19—Lapatinib—breast cancer	0.008	0.0197	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—breast cancer	0.00791	0.0195	CbGbCtD
Omeprazole—CYP3A4—Exemestane—breast cancer	0.00764	0.0189	CbGbCtD
Omeprazole—CYP2C9—Idarubicin—breast cancer	0.00755	0.0187	CbGbCtD
Omeprazole—CYP2C8—Raloxifene—breast cancer	0.00722	0.0178	CbGbCtD
Omeprazole—ABCG2—Paclitaxel—breast cancer	0.00697	0.0172	CbGbCtD
Omeprazole—CYP11A1—corpus luteum—breast cancer	0.00692	0.255	CbGeAlD
Omeprazole—CYP2D6—Idarubicin—breast cancer	0.00691	0.0171	CbGbCtD
Omeprazole—ABCG2—Irinotecan—breast cancer	0.00688	0.017	CbGbCtD
Omeprazole—ABCG2—Fluorouracil—breast cancer	0.0066	0.0163	CbGbCtD
Omeprazole—ABCG2—Carboplatin—breast cancer	0.00656	0.0162	CbGbCtD
Omeprazole—CYP3A4—Letrozole—breast cancer	0.0065	0.0161	CbGbCtD
Omeprazole—ABCB1—Lapatinib—breast cancer	0.00645	0.0159	CbGbCtD
Omeprazole—CYP3A4—Anastrozole—breast cancer	0.00579	0.0143	CbGbCtD
Omeprazole—CYP3A4—Toremifene—breast cancer	0.0053	0.0131	CbGbCtD
Omeprazole—ABCG2—Docetaxel—breast cancer	0.00504	0.0125	CbGbCtD
Omeprazole—CYP3A4—Fulvestrant—breast cancer	0.00493	0.0122	CbGbCtD
Omeprazole—CYP2C8—Tamoxifen—breast cancer	0.00477	0.0118	CbGbCtD
Omeprazole—CYP3A4—Thiotepa—breast cancer	0.00439	0.0108	CbGbCtD
Omeprazole—CYP2C9—Capecitabine—breast cancer	0.00414	0.0102	CbGbCtD
Omeprazole—CYP3A4—Ixabepilone—breast cancer	0.00402	0.00992	CbGbCtD
Omeprazole—CYP2C19—Tamoxifen—breast cancer	0.004	0.00989	CbGbCtD
Omeprazole—CYP3A4—Lapatinib—breast cancer	0.00387	0.00955	CbGbCtD
Omeprazole—ABCG2—Doxorubicin—breast cancer	0.00376	0.00928	CbGbCtD
Omeprazole—CYP2C8—Paclitaxel—breast cancer	0.00371	0.00918	CbGbCtD
Omeprazole—CYP1A2—Tamoxifen—breast cancer	0.00369	0.00912	CbGbCtD
Omeprazole—ABCG2—Methotrexate—breast cancer	0.00364	0.00899	CbGbCtD
Omeprazole—ABCB1—Vinorelbine—breast cancer	0.00358	0.00884	CbGbCtD
Omeprazole—CYP2C8—Fluorouracil—breast cancer	0.00352	0.00869	CbGbCtD
Omeprazole—CYP2D6—Vinorelbine—breast cancer	0.00337	0.00833	CbGbCtD
Omeprazole—CYP2C9—Tamoxifen—breast cancer	0.00333	0.00822	CbGbCtD
Omeprazole—ABCB1—Tamoxifen—breast cancer	0.00323	0.00798	CbGbCtD
Omeprazole—ABCB1—Mitoxantrone—breast cancer	0.00315	0.00778	CbGbCtD
Omeprazole—CYP2D6—Tamoxifen—breast cancer	0.00304	0.00752	CbGbCtD
Omeprazole—CYP3A4—Raloxifene—breast cancer	0.00293	0.00724	CbGbCtD
Omeprazole—ABCB1—Gemcitabine—breast cancer	0.00278	0.00687	CbGbCtD
Omeprazole—CYP1A2—Fluorouracil—breast cancer	0.00272	0.00672	CbGbCtD
Omeprazole—CYP2C9—Paclitaxel—breast cancer	0.00259	0.0064	CbGbCtD
Omeprazole—ABCB1—Paclitaxel—breast cancer	0.00251	0.00621	CbGbCtD
Omeprazole—ABCB1—Irinotecan—breast cancer	0.00248	0.00613	CbGbCtD
Omeprazole—CYP2C9—Fluorouracil—breast cancer	0.00245	0.00606	CbGbCtD
Omeprazole—ABCB1—Vinblastine—breast cancer	0.00221	0.00545	CbGbCtD
Omeprazole—CYP3A4—Vinorelbine—breast cancer	0.00214	0.0053	CbGbCtD
Omeprazole—CYP2D6—Vinblastine—breast cancer	0.00208	0.00513	CbGbCtD
Omeprazole—CYP3A4—Tamoxifen—breast cancer	0.00194	0.00478	CbGbCtD
Omeprazole—CYP3A4—Mitoxantrone—breast cancer	0.00189	0.00466	CbGbCtD
Omeprazole—ABCB1—Docetaxel—breast cancer	0.00182	0.00449	CbGbCtD
Omeprazole—CYP3A4—Paclitaxel—breast cancer	0.00151	0.00372	CbGbCtD
Omeprazole—CYP3A4—Irinotecan—breast cancer	0.00149	0.00367	CbGbCtD
Omeprazole—ABCB1—Doxorubicin—breast cancer	0.00136	0.00335	CbGbCtD
Omeprazole—CYP3A4—Vinblastine—breast cancer	0.00132	0.00326	CbGbCtD
Omeprazole—ATP4B—endocrine gland—breast cancer	0.00132	0.0485	CbGeAlD
Omeprazole—ABCB1—Methotrexate—breast cancer	0.00131	0.00324	CbGbCtD
Omeprazole—CYP2D6—Doxorubicin—breast cancer	0.00128	0.00315	CbGbCtD
Omeprazole—CYP3A4—Docetaxel—breast cancer	0.00109	0.00269	CbGbCtD
Omeprazole—ATP4A—epithelium—breast cancer	0.000911	0.0336	CbGeAlD
Omeprazole—CYP3A4—Doxorubicin—breast cancer	0.000812	0.00201	CbGbCtD
Omeprazole—ATP4A—female reproductive system—breast cancer	0.000677	0.0249	CbGeAlD
Omeprazole—ATP4A—adrenal gland—breast cancer	0.000661	0.0243	CbGeAlD
Omeprazole—CYP1B1—mammary gland—breast cancer	0.000652	0.024	CbGeAlD
Omeprazole—Pantoprazole—SLCO1B1—breast cancer	0.00062	0.203	CrCbGaD
Omeprazole—ATP4A—endocrine gland—breast cancer	0.000573	0.0211	CbGeAlD
Omeprazole—CYP2C8—mammary gland—breast cancer	0.000499	0.0184	CbGeAlD
Omeprazole—CYP11A1—adipose tissue—breast cancer	0.000483	0.0178	CbGeAlD
Omeprazole—CYP2C18—endocrine gland—breast cancer	0.000471	0.0173	CbGeAlD
Omeprazole—CYP11A1—female reproductive system—breast cancer	0.000444	0.0163	CbGeAlD
Omeprazole—CYP2C9—mammary gland—breast cancer	0.000443	0.0163	CbGeAlD
Omeprazole—CYP11A1—adrenal gland—breast cancer	0.000433	0.016	CbGeAlD
Omeprazole—CYP11A1—female gonad—breast cancer	0.000404	0.0149	CbGeAlD
Omeprazole—CYP1A2—nipple—breast cancer	0.000386	0.0142	CbGeAlD
Omeprazole—CYP1A1—nipple—breast cancer	0.000381	0.014	CbGeAlD
Omeprazole—CYP11A1—endocrine gland—breast cancer	0.000376	0.0138	CbGeAlD
Omeprazole—ABCC3—adipose tissue—breast cancer	0.000375	0.0138	CbGeAlD
Omeprazole—CYP1B1—skin of body—breast cancer	0.000345	0.0127	CbGeAlD
Omeprazole—ABCC3—female reproductive system—breast cancer	0.000344	0.0127	CbGeAlD
Omeprazole—ABCC3—adrenal gland—breast cancer	0.000336	0.0124	CbGeAlD
Omeprazole—ABCC3—female gonad—breast cancer	0.000313	0.0115	CbGeAlD
Omeprazole—CYP1B1—uterus—breast cancer	0.0003	0.011	CbGeAlD
Omeprazole—CYP1B1—pituitary gland—breast cancer	0.000294	0.0108	CbGeAlD
Omeprazole—CYP1B1—adipose tissue—breast cancer	0.000293	0.0108	CbGeAlD
Omeprazole—Lansoprazole—CYP1B1—breast cancer	0.000292	0.0957	CrCbGaD
Omeprazole—ABCC3—endocrine gland—breast cancer	0.000291	0.0107	CbGeAlD
Omeprazole—Rabeprazole—ABCG2—breast cancer	0.00027	0.0885	CrCbGaD
Omeprazole—Pantoprazole—ABCG2—breast cancer	0.00027	0.0885	CrCbGaD
Omeprazole—CYP1B1—female reproductive system—breast cancer	0.00027	0.00993	CbGeAlD
Omeprazole—CYP1B1—adrenal gland—breast cancer	0.000263	0.00969	CbGeAlD
Omeprazole—CYP11A1—lymph node—breast cancer	0.00026	0.00956	CbGeAlD
Omeprazole—CYP1A1—epithelium—breast cancer	0.000256	0.00945	CbGeAlD
Omeprazole—CYP2C8—endometrium—breast cancer	0.000249	0.00918	CbGeAlD
Omeprazole—CYP1B1—female gonad—breast cancer	0.000245	0.00903	CbGeAlD
Omeprazole—CYP1A1—skin of body—breast cancer	0.000244	0.00899	CbGeAlD
Omeprazole—ABCG2—endometrium—breast cancer	0.000242	0.00892	CbGeAlD
Omeprazole—CYP1B1—endocrine gland—breast cancer	0.000228	0.0084	CbGeAlD
Omeprazole—CYP2C8—pituitary gland—breast cancer	0.000225	0.00831	CbGeAlD
Omeprazole—ABCG2—uterus—breast cancer	0.000223	0.00822	CbGeAlD
Omeprazole—ABCG2—pituitary gland—breast cancer	0.000219	0.00808	CbGeAlD
Omeprazole—ABCG2—adipose tissue—breast cancer	0.000218	0.00804	CbGeAlD
Omeprazole—CYP1A1—uterus—breast cancer	0.000212	0.00781	CbGeAlD
Omeprazole—Rabeprazole—CYP1A1—breast cancer	0.000211	0.0693	CrCbGaD
Omeprazole—CYP1A1—adipose tissue—breast cancer	0.000207	0.00764	CbGeAlD
Omeprazole—CYP2C8—female reproductive system—breast cancer	0.000206	0.0076	CbGeAlD
Omeprazole—ABCC3—lymph node—breast cancer	0.000201	0.00742	CbGeAlD
Omeprazole—Lansoprazole—ABCG2—breast cancer	0.000201	0.066	CrCbGaD
Omeprazole—CYP2C19—endocrine gland—breast cancer	0.0002	0.00737	CbGeAlD
Omeprazole—ABCG2—adrenal gland—breast cancer	0.000196	0.00721	CbGeAlD
Omeprazole—CYP1A1—female reproductive system—breast cancer	0.000191	0.00702	CbGeAlD
Omeprazole—ABCG2—bone marrow—breast cancer	0.000189	0.00698	CbGeAlD
Omeprazole—Esomeprazole—CYP3A4—breast cancer	0.000187	0.0612	CrCbGaD
Omeprazole—CYP2C9—female reproductive system—breast cancer	0.000183	0.00675	CbGeAlD
Omeprazole—ABCG2—female gonad—breast cancer	0.000183	0.00673	CbGeAlD
Omeprazole—CYP2C8—endocrine gland—breast cancer	0.000175	0.00643	CbGeAlD
Omeprazole—CYP1A1—female gonad—breast cancer	0.000173	0.00639	CbGeAlD
Omeprazole—CYP1A2—endocrine gland—breast cancer	0.000163	0.00602	CbGeAlD
Omeprazole—ABCB1—embryo—breast cancer	0.000163	0.00601	CbGeAlD
Omeprazole—CYP1A1—endocrine gland—breast cancer	0.000161	0.00594	CbGeAlD
Omeprazole—CYP1B1—lymph node—breast cancer	0.000158	0.00581	CbGeAlD
Omeprazole—Lansoprazole—CYP1A1—breast cancer	0.000158	0.0517	CrCbGaD
Omeprazole—Rabeprazole—CYP2D6—breast cancer	0.000157	0.0516	CrCbGaD
Omeprazole—CYP2C9—endocrine gland—breast cancer	0.000155	0.00572	CbGeAlD
Omeprazole—CYP3A4—female reproductive system—breast cancer	0.00014	0.00515	CbGeAlD
Omeprazole—CYP2D6—female reproductive system—breast cancer	0.000138	0.00507	CbGeAlD
Omeprazole—Pantoprazole—CYP3A4—breast cancer	0.000135	0.0443	CrCbGaD
Omeprazole—Rabeprazole—CYP3A4—breast cancer	0.000135	0.0443	CrCbGaD
Omeprazole—ABCB1—epithelium—breast cancer	0.000133	0.00491	CbGeAlD
Omeprazole—CYP2D6—female gonad—breast cancer	0.000125	0.00461	CbGeAlD
Omeprazole—ABCB1—endometrium—breast cancer	0.000119	0.0044	CbGeAlD
Omeprazole—CYP3A4—endocrine gland—breast cancer	0.000118	0.00436	CbGeAlD
Omeprazole—ABCG2—lymph node—breast cancer	0.000117	0.00432	CbGeAlD
Omeprazole—Lansoprazole—CYP2D6—breast cancer	0.000117	0.0385	CrCbGaD
Omeprazole—CYP2D6—endocrine gland—breast cancer	0.000116	0.00429	CbGeAlD
Omeprazole—Pantoprazole—ABCB1—breast cancer	0.000112	0.0368	CrCbGaD
Omeprazole—CYP1A1—lymph node—breast cancer	0.000111	0.00411	CbGeAlD
Omeprazole—ABCB1—uterus—breast cancer	0.00011	0.00406	CbGeAlD
Omeprazole—ABCB1—pituitary gland—breast cancer	0.000108	0.00398	CbGeAlD
Omeprazole—ABCB1—adipose tissue—breast cancer	0.000108	0.00397	CbGeAlD
Omeprazole—Lansoprazole—CYP3A4—breast cancer	0.000101	0.033	CrCbGaD
Omeprazole—ABCB1—female reproductive system—breast cancer	9.9e-05	0.00365	CbGeAlD
Omeprazole—ABCB1—adrenal gland—breast cancer	9.66e-05	0.00356	CbGeAlD
Omeprazole—ABCB1—bone marrow—breast cancer	9.34e-05	0.00344	CbGeAlD
Omeprazole—ABCB1—female gonad—breast cancer	9.01e-05	0.00332	CbGeAlD
Omeprazole—ABCB1—endocrine gland—breast cancer	8.38e-05	0.00308	CbGeAlD
Omeprazole—Lansoprazole—ABCB1—breast cancer	8.37e-05	0.0275	CrCbGaD
Omeprazole—ABCB1—lymph node—breast cancer	5.79e-05	0.00213	CbGeAlD
Omeprazole—Dyspepsia—Docetaxel—breast cancer	1.82e-05	0.00013	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—breast cancer	1.82e-05	0.00013	CcSEcCtD
Omeprazole—Insomnia—Capecitabine—breast cancer	1.81e-05	0.00013	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—breast cancer	1.81e-05	0.00013	CcSEcCtD
Omeprazole—Rash—Fluorouracil—breast cancer	1.81e-05	0.000129	CcSEcCtD
Omeprazole—Dermatitis—Fluorouracil—breast cancer	1.8e-05	0.000129	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—breast cancer	1.8e-05	0.000129	CcSEcCtD
Omeprazole—Paraesthesia—Capecitabine—breast cancer	1.8e-05	0.000129	CcSEcCtD
Omeprazole—Decreased appetite—Docetaxel—breast cancer	1.8e-05	0.000129	CcSEcCtD
Omeprazole—Hypersensitivity—Paclitaxel—breast cancer	1.8e-05	0.000129	CcSEcCtD
Omeprazole—Headache—Fluorouracil—breast cancer	1.79e-05	0.000129	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—breast cancer	1.79e-05	0.000129	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—breast cancer	1.79e-05	0.000128	CcSEcCtD
Omeprazole—Dysgeusia—Methotrexate—breast cancer	1.79e-05	0.000128	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Docetaxel—breast cancer	1.78e-05	0.000128	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—breast cancer	1.78e-05	0.000128	CcSEcCtD
Omeprazole—Dyspnoea—Capecitabine—breast cancer	1.78e-05	0.000128	CcSEcCtD
Omeprazole—Fatigue—Docetaxel—breast cancer	1.78e-05	0.000128	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—breast cancer	1.78e-05	0.000128	CcSEcCtD
Omeprazole—Nausea—Mitoxantrone—breast cancer	1.78e-05	0.000127	CcSEcCtD
Omeprazole—Nausea—Irinotecan—breast cancer	1.78e-05	0.000127	CcSEcCtD
Omeprazole—Immune system disorder—Epirubicin—breast cancer	1.77e-05	0.000127	CcSEcCtD
Omeprazole—Mediastinal disorder—Epirubicin—breast cancer	1.77e-05	0.000127	CcSEcCtD
Omeprazole—Pain—Docetaxel—breast cancer	1.77e-05	0.000127	CcSEcCtD
Omeprazole—Constipation—Docetaxel—breast cancer	1.77e-05	0.000127	CcSEcCtD
Omeprazole—Back pain—Methotrexate—breast cancer	1.77e-05	0.000127	CcSEcCtD
Omeprazole—Dyspepsia—Capecitabine—breast cancer	1.76e-05	0.000126	CcSEcCtD
Omeprazole—Chills—Epirubicin—breast cancer	1.76e-05	0.000126	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—breast cancer	1.75e-05	0.000125	CcSEcCtD
Omeprazole—Asthenia—Paclitaxel—breast cancer	1.75e-05	0.000125	CcSEcCtD
Omeprazole—Decreased appetite—Capecitabine—breast cancer	1.74e-05	0.000125	CcSEcCtD
Omeprazole—Alopecia—Epirubicin—breast cancer	1.73e-05	0.000124	CcSEcCtD
Omeprazole—Nausea—Gemcitabine—breast cancer	1.73e-05	0.000124	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Capecitabine—breast cancer	1.73e-05	0.000124	CcSEcCtD
Omeprazole—Fatigue—Capecitabine—breast cancer	1.73e-05	0.000124	CcSEcCtD
Omeprazole—Pruritus—Paclitaxel—breast cancer	1.73e-05	0.000124	CcSEcCtD
Omeprazole—Vision blurred—Methotrexate—breast cancer	1.72e-05	0.000123	CcSEcCtD
Omeprazole—Mental disorder—Epirubicin—breast cancer	1.72e-05	0.000123	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—breast cancer	1.72e-05	0.000123	CcSEcCtD
Omeprazole—Constipation—Capecitabine—breast cancer	1.71e-05	0.000123	CcSEcCtD
Omeprazole—Pain—Capecitabine—breast cancer	1.71e-05	0.000123	CcSEcCtD
Omeprazole—Malnutrition—Epirubicin—breast cancer	1.71e-05	0.000122	CcSEcCtD
Omeprazole—Feeling abnormal—Docetaxel—breast cancer	1.7e-05	0.000122	CcSEcCtD
Omeprazole—Nausea—Fluorouracil—breast cancer	1.7e-05	0.000122	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—breast cancer	1.7e-05	0.000122	CcSEcCtD
Omeprazole—Ill-defined disorder—Methotrexate—breast cancer	1.69e-05	0.000121	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—breast cancer	1.69e-05	0.000121	CcSEcCtD
Omeprazole—Gastrointestinal pain—Docetaxel—breast cancer	1.69e-05	0.000121	CcSEcCtD
Omeprazole—Anaemia—Methotrexate—breast cancer	1.69e-05	0.000121	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—breast cancer	1.68e-05	0.000121	CcSEcCtD
Omeprazole—Flatulence—Epirubicin—breast cancer	1.68e-05	0.000121	CcSEcCtD
Omeprazole—Tension—Epirubicin—breast cancer	1.68e-05	0.00012	CcSEcCtD
Omeprazole—Dysgeusia—Epirubicin—breast cancer	1.67e-05	0.00012	CcSEcCtD
Omeprazole—Diarrhoea—Paclitaxel—breast cancer	1.67e-05	0.00012	CcSEcCtD
Omeprazole—Nervousness—Epirubicin—breast cancer	1.66e-05	0.000119	CcSEcCtD
Omeprazole—Back pain—Epirubicin—breast cancer	1.65e-05	0.000118	CcSEcCtD
Omeprazole—Feeling abnormal—Capecitabine—breast cancer	1.65e-05	0.000118	CcSEcCtD
Omeprazole—Malaise—Methotrexate—breast cancer	1.65e-05	0.000118	CcSEcCtD
Omeprazole—Muscle spasms—Epirubicin—breast cancer	1.64e-05	0.000118	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—breast cancer	1.64e-05	0.000118	CcSEcCtD
Omeprazole—Vertigo—Methotrexate—breast cancer	1.64e-05	0.000118	CcSEcCtD
Omeprazole—Gastrointestinal pain—Capecitabine—breast cancer	1.64e-05	0.000117	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—breast cancer	1.64e-05	0.000117	CcSEcCtD
Omeprazole—Abdominal pain—Docetaxel—breast cancer	1.63e-05	0.000117	CcSEcCtD
Omeprazole—Body temperature increased—Docetaxel—breast cancer	1.63e-05	0.000117	CcSEcCtD
Omeprazole—Leukopenia—Methotrexate—breast cancer	1.63e-05	0.000117	CcSEcCtD
Omeprazole—Chills—Doxorubicin—breast cancer	1.63e-05	0.000117	CcSEcCtD
Omeprazole—Dizziness—Paclitaxel—breast cancer	1.61e-05	0.000116	CcSEcCtD
Omeprazole—Vision blurred—Epirubicin—breast cancer	1.61e-05	0.000115	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—breast cancer	1.6e-05	0.000115	CcSEcCtD
Omeprazole—Cough—Methotrexate—breast cancer	1.59e-05	0.000114	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—breast cancer	1.59e-05	0.000114	CcSEcCtD
Omeprazole—Urticaria—Capecitabine—breast cancer	1.59e-05	0.000114	CcSEcCtD
Omeprazole—Ill-defined disorder—Epirubicin—breast cancer	1.58e-05	0.000114	CcSEcCtD
Omeprazole—Abdominal pain—Capecitabine—breast cancer	1.58e-05	0.000113	CcSEcCtD
Omeprazole—Body temperature increased—Capecitabine—breast cancer	1.58e-05	0.000113	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—breast cancer	1.58e-05	0.000113	CcSEcCtD
Omeprazole—Anaemia—Epirubicin—breast cancer	1.58e-05	0.000113	CcSEcCtD
Omeprazole—Agitation—Epirubicin—breast cancer	1.57e-05	0.000113	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—breast cancer	1.56e-05	0.000112	CcSEcCtD
Omeprazole—Myalgia—Methotrexate—breast cancer	1.55e-05	0.000111	CcSEcCtD
Omeprazole—Arthralgia—Methotrexate—breast cancer	1.55e-05	0.000111	CcSEcCtD
Omeprazole—Chest pain—Methotrexate—breast cancer	1.55e-05	0.000111	CcSEcCtD
Omeprazole—Tension—Doxorubicin—breast cancer	1.55e-05	0.000111	CcSEcCtD
Omeprazole—Vomiting—Paclitaxel—breast cancer	1.55e-05	0.000111	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—breast cancer	1.55e-05	0.000111	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.54e-05	0.000111	CcSEcCtD
Omeprazole—Malaise—Epirubicin—breast cancer	1.54e-05	0.00011	CcSEcCtD
Omeprazole—Rash—Paclitaxel—breast cancer	1.54e-05	0.00011	CcSEcCtD
Omeprazole—Dermatitis—Paclitaxel—breast cancer	1.54e-05	0.00011	CcSEcCtD
Omeprazole—Discomfort—Methotrexate—breast cancer	1.54e-05	0.00011	CcSEcCtD
Omeprazole—Nervousness—Doxorubicin—breast cancer	1.53e-05	0.00011	CcSEcCtD
Omeprazole—Vertigo—Epirubicin—breast cancer	1.53e-05	0.00011	CcSEcCtD
Omeprazole—Leukopenia—Epirubicin—breast cancer	1.53e-05	0.00011	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—breast cancer	1.53e-05	0.00011	CcSEcCtD
Omeprazole—Headache—Paclitaxel—breast cancer	1.53e-05	0.00011	CcSEcCtD
Omeprazole—Hypersensitivity—Docetaxel—breast cancer	1.52e-05	0.000109	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—breast cancer	1.52e-05	0.000109	CcSEcCtD
Omeprazole—Palpitations—Epirubicin—breast cancer	1.51e-05	0.000108	CcSEcCtD
Omeprazole—Confusional state—Methotrexate—breast cancer	1.5e-05	0.000108	CcSEcCtD
Omeprazole—Cough—Epirubicin—breast cancer	1.49e-05	0.000107	CcSEcCtD
Omeprazole—Anaphylactic shock—Methotrexate—breast cancer	1.49e-05	0.000107	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—breast cancer	1.49e-05	0.000107	CcSEcCtD
Omeprazole—Asthenia—Docetaxel—breast cancer	1.48e-05	0.000106	CcSEcCtD
Omeprazole—Infection—Methotrexate—breast cancer	1.48e-05	0.000106	CcSEcCtD
Omeprazole—Hypertension—Epirubicin—breast cancer	1.47e-05	0.000106	CcSEcCtD
Omeprazole—Hypersensitivity—Capecitabine—breast cancer	1.47e-05	0.000106	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—breast cancer	1.47e-05	0.000105	CcSEcCtD
Omeprazole—Pruritus—Docetaxel—breast cancer	1.46e-05	0.000105	CcSEcCtD
Omeprazole—Nervous system disorder—Methotrexate—breast cancer	1.46e-05	0.000105	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—breast cancer	1.46e-05	0.000105	CcSEcCtD
Omeprazole—Thrombocytopenia—Methotrexate—breast cancer	1.46e-05	0.000105	CcSEcCtD
Omeprazole—Myalgia—Epirubicin—breast cancer	1.45e-05	0.000104	CcSEcCtD
Omeprazole—Arthralgia—Epirubicin—breast cancer	1.45e-05	0.000104	CcSEcCtD
Omeprazole—Chest pain—Epirubicin—breast cancer	1.45e-05	0.000104	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—breast cancer	1.45e-05	0.000104	CcSEcCtD
Omeprazole—Anxiety—Epirubicin—breast cancer	1.45e-05	0.000104	CcSEcCtD
Omeprazole—Nausea—Paclitaxel—breast cancer	1.45e-05	0.000104	CcSEcCtD
Omeprazole—Skin disorder—Methotrexate—breast cancer	1.45e-05	0.000104	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.44e-05	0.000104	CcSEcCtD
Omeprazole—Hyperhidrosis—Methotrexate—breast cancer	1.44e-05	0.000103	CcSEcCtD
Omeprazole—Discomfort—Epirubicin—breast cancer	1.44e-05	0.000103	CcSEcCtD
Omeprazole—Asthenia—Capecitabine—breast cancer	1.44e-05	0.000103	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—breast cancer	1.43e-05	0.000102	CcSEcCtD
Omeprazole—Dry mouth—Epirubicin—breast cancer	1.42e-05	0.000102	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—breast cancer	1.42e-05	0.000102	CcSEcCtD
Omeprazole—Anorexia—Methotrexate—breast cancer	1.42e-05	0.000102	CcSEcCtD
Omeprazole—Pruritus—Capecitabine—breast cancer	1.42e-05	0.000102	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—breast cancer	1.41e-05	0.000101	CcSEcCtD
Omeprazole—Diarrhoea—Docetaxel—breast cancer	1.41e-05	0.000101	CcSEcCtD
Omeprazole—Confusional state—Epirubicin—breast cancer	1.41e-05	0.000101	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—breast cancer	1.4e-05	0.0001	CcSEcCtD
Omeprazole—Anaphylactic shock—Epirubicin—breast cancer	1.39e-05	0.0001	CcSEcCtD
Omeprazole—Infection—Epirubicin—breast cancer	1.38e-05	9.93e-05	CcSEcCtD
Omeprazole—Cough—Doxorubicin—breast cancer	1.38e-05	9.89e-05	CcSEcCtD
Omeprazole—Shock—Epirubicin—breast cancer	1.37e-05	9.83e-05	CcSEcCtD
Omeprazole—Diarrhoea—Capecitabine—breast cancer	1.37e-05	9.82e-05	CcSEcCtD
Omeprazole—Nervous system disorder—Epirubicin—breast cancer	1.37e-05	9.8e-05	CcSEcCtD
Omeprazole—Dizziness—Docetaxel—breast cancer	1.37e-05	9.8e-05	CcSEcCtD
Omeprazole—Thrombocytopenia—Epirubicin—breast cancer	1.36e-05	9.79e-05	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—breast cancer	1.36e-05	9.78e-05	CcSEcCtD
Omeprazole—Tachycardia—Epirubicin—breast cancer	1.36e-05	9.76e-05	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Methotrexate—breast cancer	1.36e-05	9.73e-05	CcSEcCtD
Omeprazole—Skin disorder—Epirubicin—breast cancer	1.35e-05	9.71e-05	CcSEcCtD
Omeprazole—Hyperhidrosis—Epirubicin—breast cancer	1.35e-05	9.66e-05	CcSEcCtD
Omeprazole—Insomnia—Methotrexate—breast cancer	1.35e-05	9.66e-05	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—breast cancer	1.35e-05	9.65e-05	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—breast cancer	1.35e-05	9.65e-05	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—breast cancer	1.35e-05	9.65e-05	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—breast cancer	1.34e-05	9.62e-05	CcSEcCtD
Omeprazole—Paraesthesia—Methotrexate—breast cancer	1.34e-05	9.59e-05	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.34e-05	9.58e-05	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—breast cancer	1.33e-05	9.53e-05	CcSEcCtD
Omeprazole—Anorexia—Epirubicin—breast cancer	1.33e-05	9.53e-05	CcSEcCtD
Omeprazole—Dyspnoea—Methotrexate—breast cancer	1.33e-05	9.52e-05	CcSEcCtD
Omeprazole—Somnolence—Methotrexate—breast cancer	1.32e-05	9.5e-05	CcSEcCtD
Omeprazole—Dizziness—Capecitabine—breast cancer	1.32e-05	9.49e-05	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—breast cancer	1.32e-05	9.44e-05	CcSEcCtD
Omeprazole—Vomiting—Docetaxel—breast cancer	1.31e-05	9.42e-05	CcSEcCtD
Omeprazole—Dyspepsia—Methotrexate—breast cancer	1.31e-05	9.4e-05	CcSEcCtD
Omeprazole—Rash—Docetaxel—breast cancer	1.3e-05	9.34e-05	CcSEcCtD
Omeprazole—Dermatitis—Docetaxel—breast cancer	1.3e-05	9.34e-05	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—breast cancer	1.3e-05	9.33e-05	CcSEcCtD
Omeprazole—Decreased appetite—Methotrexate—breast cancer	1.29e-05	9.29e-05	CcSEcCtD
Omeprazole—Headache—Docetaxel—breast cancer	1.29e-05	9.28e-05	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—breast cancer	1.29e-05	9.25e-05	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Methotrexate—breast cancer	1.29e-05	9.22e-05	CcSEcCtD
Omeprazole—Fatigue—Methotrexate—breast cancer	1.28e-05	9.21e-05	CcSEcCtD
Omeprazole—Infection—Doxorubicin—breast cancer	1.28e-05	9.19e-05	CcSEcCtD
Omeprazole—Pain—Methotrexate—breast cancer	1.27e-05	9.13e-05	CcSEcCtD
Omeprazole—Vomiting—Capecitabine—breast cancer	1.27e-05	9.12e-05	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Epirubicin—breast cancer	1.27e-05	9.11e-05	CcSEcCtD
Omeprazole—Shock—Doxorubicin—breast cancer	1.27e-05	9.1e-05	CcSEcCtD
Omeprazole—Nervous system disorder—Doxorubicin—breast cancer	1.26e-05	9.07e-05	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—breast cancer	1.26e-05	9.06e-05	CcSEcCtD
Omeprazole—Rash—Capecitabine—breast cancer	1.26e-05	9.05e-05	CcSEcCtD
Omeprazole—Insomnia—Epirubicin—breast cancer	1.26e-05	9.04e-05	CcSEcCtD
Omeprazole—Dermatitis—Capecitabine—breast cancer	1.26e-05	9.04e-05	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—breast cancer	1.26e-05	9.03e-05	CcSEcCtD
Omeprazole—Headache—Capecitabine—breast cancer	1.25e-05	8.99e-05	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—breast cancer	1.25e-05	8.98e-05	CcSEcCtD
Omeprazole—Paraesthesia—Epirubicin—breast cancer	1.25e-05	8.98e-05	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—breast cancer	1.25e-05	8.94e-05	CcSEcCtD
Omeprazole—Dyspnoea—Epirubicin—breast cancer	1.24e-05	8.91e-05	CcSEcCtD
Omeprazole—Somnolence—Epirubicin—breast cancer	1.24e-05	8.89e-05	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—breast cancer	1.23e-05	8.82e-05	CcSEcCtD
Omeprazole—Nausea—Docetaxel—breast cancer	1.23e-05	8.8e-05	CcSEcCtD
Omeprazole—Feeling abnormal—Methotrexate—breast cancer	1.23e-05	8.8e-05	CcSEcCtD
Omeprazole—Dyspepsia—Epirubicin—breast cancer	1.23e-05	8.8e-05	CcSEcCtD
Omeprazole—Gastrointestinal pain—Methotrexate—breast cancer	1.22e-05	8.73e-05	CcSEcCtD
Omeprazole—Decreased appetite—Epirubicin—breast cancer	1.21e-05	8.69e-05	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Epirubicin—breast cancer	1.2e-05	8.63e-05	CcSEcCtD
Omeprazole—Fatigue—Epirubicin—breast cancer	1.2e-05	8.62e-05	CcSEcCtD
Omeprazole—Pain—Epirubicin—breast cancer	1.19e-05	8.55e-05	CcSEcCtD
Omeprazole—Constipation—Epirubicin—breast cancer	1.19e-05	8.55e-05	CcSEcCtD
Omeprazole—Nausea—Capecitabine—breast cancer	1.19e-05	8.52e-05	CcSEcCtD
Omeprazole—Urticaria—Methotrexate—breast cancer	1.18e-05	8.49e-05	CcSEcCtD
Omeprazole—Abdominal pain—Methotrexate—breast cancer	1.18e-05	8.44e-05	CcSEcCtD
Omeprazole—Body temperature increased—Methotrexate—breast cancer	1.18e-05	8.44e-05	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.18e-05	8.43e-05	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—breast cancer	1.17e-05	8.37e-05	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—breast cancer	1.16e-05	8.31e-05	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—breast cancer	1.15e-05	8.25e-05	CcSEcCtD
Omeprazole—Feeling abnormal—Epirubicin—breast cancer	1.15e-05	8.24e-05	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—breast cancer	1.15e-05	8.22e-05	CcSEcCtD
Omeprazole—Gastrointestinal pain—Epirubicin—breast cancer	1.14e-05	8.17e-05	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—breast cancer	1.14e-05	8.14e-05	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—breast cancer	1.12e-05	8.04e-05	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—breast cancer	1.11e-05	7.99e-05	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—breast cancer	1.11e-05	7.97e-05	CcSEcCtD
Omeprazole—Urticaria—Epirubicin—breast cancer	1.11e-05	7.94e-05	CcSEcCtD
Omeprazole—Pain—Doxorubicin—breast cancer	1.1e-05	7.91e-05	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—breast cancer	1.1e-05	7.91e-05	CcSEcCtD
Omeprazole—Abdominal pain—Epirubicin—breast cancer	1.1e-05	7.9e-05	CcSEcCtD
Omeprazole—Body temperature increased—Epirubicin—breast cancer	1.1e-05	7.9e-05	CcSEcCtD
Omeprazole—Hypersensitivity—Methotrexate—breast cancer	1.1e-05	7.87e-05	CcSEcCtD
Omeprazole—Asthenia—Methotrexate—breast cancer	1.07e-05	7.66e-05	CcSEcCtD
Omeprazole—Feeling abnormal—Doxorubicin—breast cancer	1.06e-05	7.62e-05	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—breast cancer	1.05e-05	7.56e-05	CcSEcCtD
Omeprazole—Pruritus—Methotrexate—breast cancer	1.05e-05	7.56e-05	CcSEcCtD
Omeprazole—Hypersensitivity—Epirubicin—breast cancer	1.03e-05	7.36e-05	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—breast cancer	1.02e-05	7.35e-05	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—breast cancer	1.02e-05	7.31e-05	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—breast cancer	1.02e-05	7.31e-05	CcSEcCtD
Omeprazole—Diarrhoea—Methotrexate—breast cancer	1.02e-05	7.31e-05	CcSEcCtD
Omeprazole—Asthenia—Epirubicin—breast cancer	1e-05	7.17e-05	CcSEcCtD
Omeprazole—Pruritus—Epirubicin—breast cancer	9.86e-06	7.07e-05	CcSEcCtD
Omeprazole—Dizziness—Methotrexate—breast cancer	9.85e-06	7.06e-05	CcSEcCtD
Omeprazole—Diarrhoea—Epirubicin—breast cancer	9.54e-06	6.84e-05	CcSEcCtD
Omeprazole—Hypersensitivity—Doxorubicin—breast cancer	9.5e-06	6.81e-05	CcSEcCtD
Omeprazole—Vomiting—Methotrexate—breast cancer	9.47e-06	6.79e-05	CcSEcCtD
Omeprazole—Rash—Methotrexate—breast cancer	9.39e-06	6.73e-05	CcSEcCtD
Omeprazole—Dermatitis—Methotrexate—breast cancer	9.38e-06	6.73e-05	CcSEcCtD
Omeprazole—Headache—Methotrexate—breast cancer	9.33e-06	6.69e-05	CcSEcCtD
Omeprazole—Asthenia—Doxorubicin—breast cancer	9.25e-06	6.64e-05	CcSEcCtD
Omeprazole—Dizziness—Epirubicin—breast cancer	9.22e-06	6.61e-05	CcSEcCtD
Omeprazole—Pruritus—Doxorubicin—breast cancer	9.13e-06	6.54e-05	CcSEcCtD
Omeprazole—Vomiting—Epirubicin—breast cancer	8.86e-06	6.36e-05	CcSEcCtD
Omeprazole—Nausea—Methotrexate—breast cancer	8.85e-06	6.34e-05	CcSEcCtD
Omeprazole—Diarrhoea—Doxorubicin—breast cancer	8.82e-06	6.33e-05	CcSEcCtD
Omeprazole—Rash—Epirubicin—breast cancer	8.79e-06	6.3e-05	CcSEcCtD
Omeprazole—Dermatitis—Epirubicin—breast cancer	8.78e-06	6.3e-05	CcSEcCtD
Omeprazole—Headache—Epirubicin—breast cancer	8.73e-06	6.26e-05	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—breast cancer	8.53e-06	6.12e-05	CcSEcCtD
Omeprazole—Nausea—Epirubicin—breast cancer	8.28e-06	5.94e-05	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—breast cancer	8.2e-06	5.88e-05	CcSEcCtD
Omeprazole—Rash—Doxorubicin—breast cancer	8.13e-06	5.83e-05	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—breast cancer	8.12e-06	5.83e-05	CcSEcCtD
Omeprazole—Headache—Doxorubicin—breast cancer	8.08e-06	5.79e-05	CcSEcCtD
Omeprazole—Nausea—Doxorubicin—breast cancer	7.66e-06	5.49e-05	CcSEcCtD
Omeprazole—CYP2D6—Metabolism—CYP1B1—breast cancer	1.75e-06	2.17e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ERCC2—breast cancer	1.75e-06	2.17e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—STK11—breast cancer	1.75e-06	2.17e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP19A1—breast cancer	1.75e-06	2.17e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS1—breast cancer	1.75e-06	2.16e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ENO1—breast cancer	1.75e-06	2.16e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.74e-06	2.15e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1B1—breast cancer	1.74e-06	2.15e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—TYMS—breast cancer	1.73e-06	2.14e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CB—breast cancer	1.72e-06	2.13e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.72e-06	2.13e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.72e-06	2.13e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP2D6—breast cancer	1.71e-06	2.12e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PLA2G4A—breast cancer	1.71e-06	2.11e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTM1—breast cancer	1.71e-06	2.11e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NCOR1—breast cancer	1.71e-06	2.11e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—breast cancer	1.7e-06	2.11e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.7e-06	2.11e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—NOS3—breast cancer	1.69e-06	2.1e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.68e-06	2.08e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NCOA2—breast cancer	1.68e-06	2.08e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NCOA1—breast cancer	1.67e-06	2.07e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—COMT—breast cancer	1.66e-06	2.06e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTP1—breast cancer	1.66e-06	2.05e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NCOA1—breast cancer	1.66e-06	2.05e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—STK11—breast cancer	1.65e-06	2.04e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP19A1—breast cancer	1.65e-06	2.04e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—MTHFR—breast cancer	1.64e-06	2.04e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—breast cancer	1.64e-06	2.04e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—HMOX1—breast cancer	1.63e-06	2.02e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GPX1—breast cancer	1.63e-06	2.02e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP19A1—breast cancer	1.63e-06	2.02e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—STK11—breast cancer	1.63e-06	2.02e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ITPR1—breast cancer	1.63e-06	2.02e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—FASN—breast cancer	1.63e-06	2.02e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MED12—breast cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—DPYD—breast cancer	1.63e-06	2.01e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—COMT—breast cancer	1.62e-06	2.01e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—BCHE—breast cancer	1.62e-06	2.01e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTP1—breast cancer	1.62e-06	2e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP1A1—breast cancer	1.62e-06	2e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ERCC2—breast cancer	1.6e-06	1.99e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC5A5—breast cancer	1.6e-06	1.99e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALDOA—breast cancer	1.6e-06	1.98e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—HMOX1—breast cancer	1.59e-06	1.98e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ITPR1—breast cancer	1.59e-06	1.97e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ABCB1—breast cancer	1.57e-06	1.94e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CB—breast cancer	1.56e-06	1.94e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NCOA3—breast cancer	1.55e-06	1.92e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—breast cancer	1.55e-06	1.92e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC2A1—breast cancer	1.55e-06	1.92e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NQO1—breast cancer	1.55e-06	1.92e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC2A2—breast cancer	1.54e-06	1.91e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—TYMS—breast cancer	1.54e-06	1.91e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.53e-06	1.9e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—COMT—breast cancer	1.53e-06	1.9e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTP1—breast cancer	1.52e-06	1.89e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.52e-06	1.89e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NCOR1—breast cancer	1.52e-06	1.89e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTM1—breast cancer	1.52e-06	1.89e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—COMT—breast cancer	1.52e-06	1.88e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CAV1—breast cancer	1.52e-06	1.88e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.52e-06	1.88e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MTR—breast cancer	1.51e-06	1.87e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCG2—breast cancer	1.51e-06	1.87e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CPT1A—breast cancer	1.51e-06	1.87e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTP1—breast cancer	1.51e-06	1.87e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP3A4—breast cancer	1.51e-06	1.87e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—MTHFR—breast cancer	1.51e-06	1.87e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—TYMS—breast cancer	1.5e-06	1.86e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—HMOX1—breast cancer	1.5e-06	1.86e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.5e-06	1.86e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ITPR1—breast cancer	1.5e-06	1.86e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—HMOX1—breast cancer	1.49e-06	1.85e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ITPR1—breast cancer	1.49e-06	1.84e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PLA2G4A—breast cancer	1.49e-06	1.84e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTM1—breast cancer	1.49e-06	1.84e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NCOR1—breast cancer	1.49e-06	1.84e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTEN—breast cancer	1.49e-06	1.84e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP1B1—breast cancer	1.48e-06	1.84e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HPGDS—breast cancer	1.48e-06	1.84e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HBA1—breast cancer	1.47e-06	1.82e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GPX1—breast cancer	1.46e-06	1.81e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.46e-06	1.8e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.45e-06	1.8e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP1A1—breast cancer	1.44e-06	1.79e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ABCB1—breast cancer	1.44e-06	1.79e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ACHE—breast cancer	1.44e-06	1.78e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTT1—breast cancer	1.44e-06	1.78e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ERCC2—breast cancer	1.43e-06	1.77e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ABCB1—breast cancer	1.43e-06	1.77e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GPX1—breast cancer	1.42e-06	1.76e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—breast cancer	1.42e-06	1.76e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—TYMS—breast cancer	1.42e-06	1.76e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NCOA1—breast cancer	1.42e-06	1.75e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP1A1—breast cancer	1.41e-06	1.75e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—TYMS—breast cancer	1.4e-06	1.74e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTM1—breast cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NCOR1—breast cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ERCC2—breast cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—STK11—breast cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP19A1—breast cancer	1.4e-06	1.73e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CAV1—breast cancer	1.39e-06	1.72e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTM1—breast cancer	1.39e-06	1.72e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.39e-06	1.72e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NCOR1—breast cancer	1.39e-06	1.72e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—breast cancer	1.38e-06	1.71e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CG—breast cancer	1.38e-06	1.71e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP17A1—breast cancer	1.36e-06	1.69e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTEN—breast cancer	1.35e-06	1.67e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS1—breast cancer	1.35e-06	1.67e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ENO1—breast cancer	1.35e-06	1.67e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—MTHFR—breast cancer	1.35e-06	1.67e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AKT1—breast cancer	1.34e-06	1.66e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GPX1—breast cancer	1.34e-06	1.66e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GPX1—breast cancer	1.33e-06	1.65e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.33e-06	1.65e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP1A1—breast cancer	1.33e-06	1.64e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP2D6—breast cancer	1.32e-06	1.64e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ERCC2—breast cancer	1.32e-06	1.63e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1A1—breast cancer	1.32e-06	1.63e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—MTHFR—breast cancer	1.31e-06	1.63e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.31e-06	1.62e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ERCC2—breast cancer	1.31e-06	1.62e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—COMT—breast cancer	1.3e-06	1.61e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NCOA2—breast cancer	1.3e-06	1.61e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTP1—breast cancer	1.29e-06	1.6e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—HMOX1—breast cancer	1.27e-06	1.58e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ITPR1—breast cancer	1.27e-06	1.57e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CG—breast cancer	1.27e-06	1.57e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—FASN—breast cancer	1.26e-06	1.56e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—BCHE—breast cancer	1.25e-06	1.55e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CAV1—breast cancer	1.24e-06	1.54e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—MTHFR—breast cancer	1.24e-06	1.53e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC5A5—breast cancer	1.24e-06	1.53e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—MTHFR—breast cancer	1.23e-06	1.52e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ABCB1—breast cancer	1.22e-06	1.51e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CD—breast cancer	1.21e-06	1.5e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CAV1—breast cancer	1.21e-06	1.5e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—TYMS—breast cancer	1.2e-06	1.49e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ALB—breast cancer	1.2e-06	1.49e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC2A1—breast cancer	1.19e-06	1.48e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NQO1—breast cancer	1.19e-06	1.48e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTM1—breast cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NCOR1—breast cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.19e-06	1.47e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—breast cancer	1.16e-06	1.44e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NOS3—breast cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1B1—breast cancer	1.15e-06	1.42e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CAV1—breast cancer	1.14e-06	1.41e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GPX1—breast cancer	1.14e-06	1.41e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CAV1—breast cancer	1.13e-06	1.4e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CG—breast cancer	1.13e-06	1.4e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—breast cancer	1.13e-06	1.4e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP1A1—breast cancer	1.12e-06	1.39e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.12e-06	1.39e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ERCC2—breast cancer	1.12e-06	1.38e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CD—breast cancer	1.11e-06	1.38e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CG—breast cancer	1.1e-06	1.37e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ALB—breast cancer	1.1e-06	1.36e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NCOA1—breast cancer	1.09e-06	1.35e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.08e-06	1.34e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP19A1—breast cancer	1.08e-06	1.33e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—STK11—breast cancer	1.08e-06	1.33e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CB—breast cancer	1.06e-06	1.31e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NOS3—breast cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—breast cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—MTHFR—breast cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—breast cancer	1.05e-06	1.3e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CG—breast cancer	1.04e-06	1.29e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CG—breast cancer	1.03e-06	1.28e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—COMT—breast cancer	1e-06	1.24e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTP1—breast cancer	9.96e-07	1.23e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CD—breast cancer	9.94e-07	1.23e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—HMOX1—breast cancer	9.83e-07	1.22e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALB—breast cancer	9.81e-07	1.22e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ITPR1—breast cancer	9.8e-07	1.21e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CB—breast cancer	9.7e-07	1.2e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CD—breast cancer	9.7e-07	1.2e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CAV1—breast cancer	9.67e-07	1.2e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—breast cancer	9.62e-07	1.19e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALB—breast cancer	9.58e-07	1.19e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—breast cancer	9.53e-07	1.18e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCB1—breast cancer	9.43e-07	1.17e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NOS3—breast cancer	9.38e-07	1.16e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—TYMS—breast cancer	9.26e-07	1.15e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.24e-07	1.14e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NOS3—breast cancer	9.16e-07	1.13e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PLA2G4A—breast cancer	9.15e-07	1.13e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTM1—breast cancer	9.15e-07	1.13e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NCOR1—breast cancer	9.15e-07	1.13e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTEN—breast cancer	9.15e-07	1.13e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CD—breast cancer	9.14e-07	1.13e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CD—breast cancer	9.06e-07	1.12e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALB—breast cancer	9.02e-07	1.12e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALB—breast cancer	8.95e-07	1.11e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CG—breast cancer	8.81e-07	1.09e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GPX1—breast cancer	8.77e-07	1.09e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1A1—breast cancer	8.68e-07	1.08e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CB—breast cancer	8.66e-07	1.07e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NOS3—breast cancer	8.63e-07	1.07e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ERCC2—breast cancer	8.61e-07	1.07e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—breast cancer	8.58e-07	1.06e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—breast cancer	8.56e-07	1.06e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NOS3—breast cancer	8.56e-07	1.06e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CB—breast cancer	8.45e-07	1.05e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTEN—breast cancer	8.39e-07	1.04e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—breast cancer	8.38e-07	1.04e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MTHFR—breast cancer	8.09e-07	1e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CB—breast cancer	7.97e-07	9.87e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CB—breast cancer	7.9e-07	9.79e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—breast cancer	7.89e-07	9.78e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—breast cancer	7.83e-07	9.7e-06	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—breast cancer	7.79e-07	9.65e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CD—breast cancer	7.74e-07	9.59e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALB—breast cancer	7.64e-07	9.47e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTEN—breast cancer	7.48e-07	9.27e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CAV1—breast cancer	7.46e-07	9.25e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NOS3—breast cancer	7.31e-07	9.06e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTEN—breast cancer	7.31e-07	9.05e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTEN—breast cancer	6.88e-07	8.53e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTEN—breast cancer	6.82e-07	8.46e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CG—breast cancer	6.8e-07	8.42e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CB—breast cancer	6.75e-07	8.36e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—breast cancer	6.69e-07	8.29e-06	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—breast cancer	6.45e-07	7.99e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CD—breast cancer	5.98e-07	7.4e-06	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—breast cancer	5.92e-07	7.33e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALB—breast cancer	5.9e-07	7.31e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTEN—breast cancer	5.83e-07	7.23e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NOS3—breast cancer	5.64e-07	6.99e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—breast cancer	5.28e-07	6.54e-06	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—breast cancer	5.27e-07	6.53e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CB—breast cancer	5.21e-07	6.45e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—breast cancer	5.16e-07	6.39e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—breast cancer	5.15e-07	6.39e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—breast cancer	4.86e-07	6.02e-06	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—breast cancer	4.83e-07	5.99e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—breast cancer	4.81e-07	5.97e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTEN—breast cancer	4.5e-07	5.58e-06	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—breast cancer	4.31e-07	5.34e-06	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—breast cancer	4.21e-07	5.22e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—breast cancer	4.11e-07	5.1e-06	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—breast cancer	3.97e-07	4.92e-06	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—breast cancer	3.93e-07	4.87e-06	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—breast cancer	3.36e-07	4.16e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—breast cancer	3.18e-07	3.93e-06	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—breast cancer	2.59e-07	3.21e-06	CbGpPWpGaD
